Clinical trials
Terminated Phase 2 Metabolic Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2011 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AHS Cancer Control Alberta | 1 |
| Dr. B. Catharine. Craven | 1 |
| Iman Al-Naggar, PhD | 1 |
| Laval University | 1 |
| Liminal BioSciences Ltd. | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| Rottapharm Spain | 1 |
| University of California, San Francisco | 1 |
| University of Iowa | 1 |
| Virginia Commonwealth University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Syndrome | 10 |
| Obesity | 2 |
| Diabetes Mellitus, Type 2 | 1 |
| Dyslipidemias | 1 |
| Glucose Intolerance | 1 |
| Hypertension | 1 |
| Insulin Resistance | 1 |
| Lower Urinary Tract Symptoms | 1 |
| Non-alcoholic Fatty Liver Disease | 1 |
| Osteoporosis | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.